The medical landscape is witnessing a shift with the introduction of GLP-1 transdermal systems . These innovative formulations offer a possible method to providing glucagon-like peptide-1 therapies for individuals battling hyperglycemia. Instead of injections , a easy-to-use patch placed to the skin could provide a steady amount of the medication ,